Circulating fibroblast activation protein activity and antigen levels correlate strongly when measured in liver disease and coronary heart disease

作者: David Bowen , Mark Gorrell , Fiona Keane , Bhavri Maneck , Geoffrey William McCaughan

DOI: 10.1371/JOURNAL.PONE.0178987

关键词:

摘要: Background and aim Circulating fibroblast activation protein (cFAP) is a constitutively active enzyme expressed by activated fibroblasts that has both dipeptidyl peptidase endopeptidase activities. We aimed to assess the correlation between cFAP activity antigen levels compare variations in levels. Methods In plasma of 465 control individuals, 368 patients with coronary heart disease (CHD) 102 hepatitis C virus (HCV) infected severe liver before after transplant, were measured newly developed assay. In same samples, using commercially available ELISA. Correlation analyses performed calculating Pearson’s coefficient (ρ). Additionally, normal ranges, determinants differences cohorts anticoagulants investigated. Results cFAP significantly correlated controls (ρ: 0.660, p<0.001) CHD 0.709, p<0.001). HCV cohort lower samples taken transplantation (p<0.001) normalized toward healthy individuals. Furthermore, higher men associated body mass index. Also, EDTA as compared citrated from individuals. Conclusions For analyzing levels, either or can be investigate However, it importance blood are collected anticoagulant.

参考文章(20)
Fiona M. Keane, Naveed A. Nadvi, Tsun-Wen Yao, Mark D. Gorrell, Neuropeptide Y, B‐type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein‐α FEBS Journal. ,vol. 278, pp. 1316- 1332 ,(2011) , 10.1111/J.1742-4658.2011.08051.X
Jonathan D Cheng, Identification and characterization of the promoter of fibroblast activation protein Frontiers in Bioscience. ,vol. E2, pp. 1154- 1163 ,(2010) , 10.2741/E175
Kyung N. Lee, Kenneth W. Jackson, Victoria J. Christiansen, Keun H. Chung, Patrick A. McKee, A novel plasma proteinase potentiates α2-antiplasmin inhibition of fibrin digestion Blood. ,vol. 103, pp. 3783- 3788 ,(2004) , 10.1182/BLOOD-2003-12-4240
E. L. E. DE BRUIJNE, A. GILS, A. H. C. GUIMARÃES, D. W. J. DIPPEL, J. W. DECKERS, A. H. VAN DEN MEIRACKER, D. POLDERMANS, D. C. RIJKEN, P. J. DECLERCK, M. P. M. DE MAAT, F. W. G. LEEBEEK, The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC study. Journal of Thrombosis and Haemostasis. ,vol. 7, pp. 919- 927 ,(2009) , 10.1111/J.1538-7836.2009.03350.X
John E. Park, Martin C. Lenter, Rainer N. Zimmermann, Pilar Garin-Chesa, Lloyd J. Old, Wolfgang J. Rettig, Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts. Journal of Biological Chemistry. ,vol. 274, pp. 36505- 36512 ,(1999) , 10.1074/JBC.274.51.36505
M. Kraman, P. J. Bambrough, J. N. Arnold, E. W. Roberts, L. Magiera, J. O. Jones, A. Gopinathan, D. A. Tuveson, D. T. Fearon, Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein–α Science. ,vol. 330, pp. 827- 830 ,(2010) , 10.1126/SCIENCE.1195300
Mark D. Gorrell, Brenna Osborne, Tsun-Wen Yao, Xin Maggie Wang, Yiqian Chen, L. Damla Kotan, Naveed A. Nadvi, Mustafa Herdem, Geoffrey W. McCaughan, John D. Allen, Denise M.T. Yu, A. Kemal Topaloglu, A rare variant in human fibroblast activation protein associated with ER stress, loss of enzymatic function and loss of cell surface localisation. Biochimica et Biophysica Acta. ,vol. 1844, pp. 1248- 1259 ,(2014) , 10.1016/J.BBAPAP.2014.03.015
Shirley Uitte de Willige, Joyce J.M.C. Malfliet, Jaap W. Deckers, Diederik W.J. Dippel, Frank W.G. Leebeek, Dingeman C. Rijken, Plasma levels of soluble fibroblast activation protein in arterial thrombosis; determinants and cleavage of its substrate alpha-2-antiplasmin International Journal of Cardiology. ,vol. 178, pp. 105- 110 ,(2015) , 10.1016/J.IJCARD.2014.10.091
Jochen Tillmanns, Christian Widera, Yasmin Habbaba, Paolo Galuppo, Tibor Kempf, Kai C. Wollert, Johann Bauersachs, Circulating concentrations of fibroblast activation protein α in apparently healthy individuals and patients with acute coronary syndrome as assessed by sandwich ELISA. International Journal of Cardiology. ,vol. 168, pp. 3926- 3931 ,(2013) , 10.1016/J.IJCARD.2013.06.061